Sana’s stock soars on new cell therapy data; UniQure’s $75M offering

Plus, news about Bioinvent, Alpha Cognition, Neumirna Therapeutics and Cassava Sciences: Sana Biotechnology finds life with new type 1 diabetes cell therapy data: The once high-flying biotech saw its stock {$SANA} jump over 150% on ...